4//SEC Filing
Duliege Anne-Marie 4
Accession 0001179110-18-009506
CIK 0001034842other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 6:59 PM ET
Size
5.2 KB
Accession
0001179110-18-009506
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-07-02$2.79/sh−5,000$13,932→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26,2018.
- [F2]The Reporting Person purchased these shares on June 29, 2018 under the Issuer's Employee Stock Purchase Plan.
- [F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $2.76 to $2.80. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001419579
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 6:59 PM ET
- Size
- 5.2 KB